OxyPrem, the Zurich-based manufacturer of brain oxygen sensors for preterm-born children, has launched a funding campaign in collaboration with lifescience-specialized crowdinvesting platform Capital Cell. Close to EUR 1.5 million has already been invested or committed to the round.
